Roen Surgical Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 84

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $20.3M

  • Investors
  • 15

Roen Surgical General Information

Description

Developer of surgical robot systems designed to simplify complex medical processes for doctors, and medical professionals. The company creates flexible surgical robots for endoluminal surgeries in urology, gastrointestinal, and gynecology, enabling healthcare professionals to use robotic emends to solve various medical problems such as surgery simulation.

Contact Information

Formerly Known As
Easy Endo Surgical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • T122, Truth Hall, KAIST Munji Campus
  • 193 Munji-ro, T122, Yuseong-gu
  • Daejeon, 34051
  • South Korea
+82
Primary Industry
Surgical Devices
Other Industries
Decision/Risk Analysis
Corporate Office
  • T122, Truth Hall, KAIST Munji Campus
  • 193 Munji-ro, T122, Yuseong-gu
  • Daejeon, 34051
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Roen Surgical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 28-Oct-2024 $20.3M Completed Generating Revenue
4. Early Stage VC (Series A) 26-Jul-2021 Completed Generating Revenue
3. Seed Round 31-Oct-2018 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 27-Feb-2018 Completed Startup
To view Roen Surgical’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Roen Surgical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Roen Surgical Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Painters & Ventures Venture Capital Minority
Brave New Investment PE/Buyout Minority
BSK Investment Venture Capital Minority
Capstone Partners Korea Venture Capital Minority
Industrial Bank of Korea PE/Buyout Minority
You’re viewing 5 of 15 investors. Get the full list »

Roen Surgical FAQs

  • When was Roen Surgical founded?

    Roen Surgical was founded in 2018.

  • Where is Roen Surgical headquartered?

    Roen Surgical is headquartered in Daejeon, South Korea.

  • What is the size of Roen Surgical?

    Roen Surgical has 84 total employees.

  • What industry is Roen Surgical in?

    Roen Surgical’s primary industry is Surgical Devices.

  • Is Roen Surgical a private or public company?

    Roen Surgical is a Private company.

  • What is Roen Surgical’s current revenue?

    The current revenue for Roen Surgical is .

  • How much funding has Roen Surgical raised over time?

    Roen Surgical has raised $53.1M.

  • Who are Roen Surgical’s investors?

    Painters & Ventures, Brave New Investment, BSK Investment, Capstone Partners Korea, and Industrial Bank of Korea are 5 of 15 investors who have invested in Roen Surgical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process